Orchestra BioMed Holdings Inc. Total Liabilities
Orchestra BioMed Holdings Inc. total liabilities. Based on the latest financial reports, Orchestra BioMed Holdings Inc. (OBIO) has total liabilities worth $86.28 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check OBIO cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Orchestra BioMed Holdings Inc. (2020–2025)
Total liabilities of Orchestra BioMed Holdings Inc. from 2020 to 2025. This chart illustrates how Orchestra BioMed Holdings Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore Orchestra BioMed Holdings Inc. long-term investment allocation to see how much of total assets are deployed in long-term investments.
Orchestra BioMed Holdings Inc. Competitors by Total Liabilities
The table below lists competitors of Orchestra BioMed Holdings Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RCE Capital Berhad
KLSE:9296
|
Malaysia | RM2.14 Billion |
|
FLAT GLASS GROUP H YC-25
F:72T
|
Germany | €19.77 Billion |
|
Symtek Automation Asia Co Ltd
TW:6438
|
Taiwan | NT$4.76 Billion |
|
Taiwan Paiho Ltd
TW:9938
|
Taiwan | NT$17.22 Billion |
|
John Marshall Bancorp Inc
NASDAQ:JMSB
|
USA | $2.13 Billion |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥711.34 Million |
|
Aurora Cannabis Inc
TO:ACB
|
Canada | CA$93.75 Million |
|
ADTRAN Inc
NASDAQ:ADTN
|
USA | $678.52 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Orchestra BioMed Holdings Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Orchestra BioMed Holdings Inc.'s balance sheet.
Liquidity & Leverage Metrics
Orchestra BioMed Holdings Inc. Total Liabilities Ratios Explained
Orchestra BioMed Holdings Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.93 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Orchestra BioMed Holdings Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Orchestra BioMed Holdings Inc. (2020–2025)
The table below shows the annual total liabilities of Orchestra BioMed Holdings Inc. from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $51.48 Million | +19.12% |
| 2024-12-31 | $43.22 Million | +59.06% |
| 2023-12-31 | $27.17 Million | -36.87% |
| 2022-12-31 | $43.04 Million | -49.22% |
| 2021-12-31 | $84.76 Million | -2.16% |
| 2020-12-31 | $86.63 Million | -- |
About Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develop… Read more